Platelet function tests

Seminars in Thrombosis and Hemostasis

Volumn 42, Issue 3, 2016, Pages 258-267

  Lordkipanidzé, Marie ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

antiplatelet therapy; bleeding disorders; platelet function testing

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ARTICLE; BLEEDING TIME; BLEEDING TIME DEVICE; BLOOD CLOTTING PARAMETERS; BLOOD SAMPLING; FLOW CYTOMETRY; HUMAN; LIGHT TRANSMISSION AGGREGOMETRY; MICROPLATE READER; PLATELET AGGREGATION ASSAY; PRIORITY JOURNAL; THROMBOCYTE FUNCTION; THROMBOCYTE FUNCTION ANALYZER; THROMBOELASTOGRAPH; THROMBOELASTOGRAPHY; VEIN PUNCTURE; WHOLE BLOOD AGGREGOMETRY; DEVICES; DRUG MONITORING; HEMORRHAGE; PATHOPHYSIOLOGY; PHYSIOLOGY; POINT OF CARE SYSTEM; PROCEDURES; SENSITIVITY AND SPECIFICITY; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOSIS; TRENDS;

BLOOD PLATELETS; DRUG MONITORING; HEMORRHAGE; HUMANS; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; POINT-OF-CARE SYSTEMS; SENSITIVITY AND SPECIFICITY; THROMBOSIS;

EID: 84975322210     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0035-1564834     Document Type: Article

References (91)

1. Nurden A. T. Platelets, inflammation and tissue regeneration. Thromb Haemost: 2011; 105 01 S13 S33
2. McFadyen J. D., Kaplan Z. S. Platelets are not just for clots. Transfus Med Rev: 2015; 29 2 110 119
3. Gremmel T., Frelinger A. L. III, Michelson A. D. Platelet physiology. Semin Thromb Hemost: 2016; 42 3 191 204
4. Gresele P.; Subcommittee on Platelet Physiology. Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH. J Thromb Haemost: 2015; 13 2 314 322
5. Gawaz M., Langer H., May A. E. Platelets in inflammation and atherogenesis. J Clin Invest: 2005; 115 12 3378 3384
6. Ruggeri Z. M. Platelets in atherothrombosis. Nat Med: 2002; 8 11 1227 1234
7. Siller-Matula J. M., Trenk D., Schrör K., et al. European Platelet Academy. How to improve the concept of individualised antiplatelet therapy with P2Y12 receptor inhibitors-is an algorithm the answer? Thromb Haemost: 2015; 113 1 37 52
8. Petricevic M., Kopjar T., Biocina B., et al. The predictive value of platelet function point-of-care tests for postoperative blood loss and transfusion in routine cardiac surgery: a systematic review. Thorac Cardiovasc Surg: 2015; 63 1 2 20
9. Gresele P., Bury L., Falcinelli E. Inherited platelet function disorders: algorithms for phenotypic and genetic investigation. Semin Thromb Hemost: 2016; 42 3 292 305
10. Cai H., Mullier F., Frotscher B., et al. Usefulness of flow cytometric mepacrine uptake/release combined with CD63 assay in diagnosis of patients with suspected platelet dense granule disorder. Semin Thromb Hemost: 2016; 42 3 282 291
11. Gross L., Aradi D., Sibbing D. Platelet function testing in patients on antiplatelet medications. Semin Thromb Hemost: 2016; 42 3 306 320
12. Milian M. G. Technique pour l'étude clinique de la coagulation du sang. Bull Mem Soc Med Hop Paris: 1901; 18 777 783
13. Duke W. W. The relation of blood platelets to hemorrhagic disease. Description of a method for determining the bleeding time and the coagulation time and report of three cases of hemorrahagic disease relieved by blood transfusion. JAMA: 1910; 55 1185 1192
14. Ivy A. C., Nelson D., Bucher G. The standardization of certain factors in the cutaneous venostasis bleeding time technique. J Lab Clin Med: 1941; 26 1812 1822
15. Mielke C. H. Jr, Kaneshiro M. M., Maher I. A., Weiner J. M., Rapaport S. I. The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood: 1969; 34 2 204 215
16. The British Society for Haematology BCSH Haemostasis and Thrombosis Task Force Guidelines on platelet function testing. J Clin Pathol: 1988; 41 12 1322 1330
17. Rodgers R. P., Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost: 1990; 16 1 1 20
18. Lind S. E. The bleeding time does not predict surgical bleeding. Blood: 1991; 77 12 2547 2552
19. Peterson P., Hayes T. E., Arkin C. F., et al. The preoperative bleeding time test lacks clinical benefit: College of American Pathologists' and American Society of Clinical Pathologists' position article. Arch Surg: 1998; 133 2 134 139
20. Harrison P., Mackie I., Mumford A., et al. British Committee for Standards in Haematology. Guidelines for the laboratory investigation of heritable disorders of platelet function. Br J Haematol: 2011; 155 1 30 44
21. Moffat K. A., Ledford-Kraemer M. R., Nichols W. L., Hayward C. P.; North American Specialized Coagulation Laboratory Association. Variability in clinical laboratory practice in testing for disorders of platelet function: results of two surveys of the North American Specialized Coagulation Laboratory Association. Thromb Haemost: 2005; 93 3 549 553
22. Jennings I., Woods T. A., Kitchen S., Walker I. D. Platelet function testing: practice among UK National External Quality Assessment Scheme for Blood Coagulation participants, 2006. J Clin Pathol: 2008; 61 8 950 954
23. Cattaneo M., Hayward C. P., Moffat K. A., Pugliano M. T., Liu Y., Michelson A. D. Results of a worldwide survey on the assessment of platelet function by light transmission aggregometry: a report from the platelet physiology subcommittee of the SSC of the ISTH. J Thromb Haemost: 2009; 7 6 1029
24. Gresele P., Harrison P., Bury L., et al. Diagnosis of suspected inherited platelet function disorders: results of a worldwide survey. J Thromb Haemost: 2014; 12 9 1562 1569
25. Favaloro E. J. Time for a conceptual shift in assessment of internal quality control for whole blood or cell-based testing systems? An evaluation using platelet function and the PFA-100 as a case example. Clin Chem Lab Med: 2013; 51 4 767 774
26. Favaloro E. J., Bonar R. External quality assessment/proficiency testing and internal quality control for the PFA-100 and PFA-200: an update. Semin Thromb Hemost: 2014; 40 2 239 253
27. Favaloro E. J. Internal quality control and external quality assurance of platelet function tests. Semin Thromb Hemost: 2009; 35 2 139 149
28. Harrison P., Lordkipanidzé M. Testing platelet function. Hematol Oncol Clin North Am: 2013; 27 3 411 441
29. Hartley P. S. The diurnal tick-tockery of platelet biology. Platelets: 2012; 23 2 157 160
30. Davis R. B., Boyd D. G., McKinney M. E., Jones C. C. Effects of exercise and exercise conditioning on blood platelet function. Med Sci Sports Exerc: 1990; 22 1 49 53
31. Ahuja K. D., Adams M. J., Robertson I. K., Ball M. J. Acute effect of a high-carbohydrate low-fat meal on platelet aggregation. Platelets: 2009; 20 8 606 609
32. Natella F., Nardini M., Belelli F., et al. Effect of coffee drinking on platelets: inhibition of aggregation and phenols incorporation. Br J Nutr: 2008; 100 6 1276 1282
33. Varani K., Portaluppi F., Gessi S., et al. Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors: functional and biochemical aspects. Circulation: 2000; 102 3 285 289
34. Rival J., Riddle J. M., Stein P. D. Effects of chronic smoking on platelet function. Thromb Res: 1987; 45 1 75 85
35. Kottke-Marchant K., Corcoran G. The laboratory diagnosis of platelet disorders. Arch Pathol Lab Med: 2002; 126 2 133 146
36. Cattaneo M., Cerletti C., Harrison P., et al. Recommendations for the standardization of light transmission aggregometry: A consensus of the working party from the platelet physiology subcommittee of SSC/ISTH. J Thromb Haemost: 2013; 11 1183 1189
37. Favaloro E. J., Lippi G., Adcock D. M. Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis? Semin Thromb Hemost: 2008; 34 7 612 634
38. Kaiser A. F., Neubauer H., Franken C. C., Krüger J. C., Mügge A., Meves S. H. Which is the best anticoagulant for whole blood aggregometry platelet function testing? Comparison of six anticoagulants and diverse storage conditions. Platelets: 2012; 23 5 359 367
39. Thalén S., Forsling I., Eintrei J., Söderblom L., Antovic J. P. Pneumatic tube transport affects platelet function measured by multiplate electrode aggregometry. Thromb Res: 2013; 132 1 77 80
40. Femia E. A., Pugliano M., Podda G., Cattaneo M. Comparison of different procedures to prepare platelet-rich plasma for studies of platelet aggregation by light transmission aggregometry. Platelets: 2012; 23 1 7 10
41. Linnemann B., Schwonberg J., Mani H., Prochnow S., Lindhoff-Last E. Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary. J Thromb Haemost: 2008; 6 4 677 683
42. Cattaneo M., Lecchi A., Zighetti M. L., Lussana F. Platelet aggregation studies: autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count. Haematologica: 2007; 92 5 694 697
43. Born G. V. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature: 1962; 194 927 929
44. Pai M., Wang G., Moffat K. A., et al. Diagnostic usefulness of a lumi-aggregometer adenosine triphosphate release assay for the assessment of platelet function disorders. Am J Clin Pathol: 2011; 136 3 350 358
45. Hayward C. P., Moffat K. A., Raby A., et al. Development of North American consensus guidelines for medical laboratories that perform and interpret platelet function testing using light transmission aggregometry. Am J Clin Pathol: 2010; 134 6 955 963
46. Cazenave J. P., Ohlmann P., Cassel D., Eckly A., Hechler B., Gachet C. Preparation of washed platelet suspensions from human and rodent blood. Methods Mol Biol: 2004; 272 13 28
47. Dawood B. B., Lowe G. C., Lordkipanidzé M., et al. Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel. Blood: 2012; 120 25 5041 5049
48. Lawrie A. S., Kobayashi K., Lane P. J., Mackie I. J., Machin S. J. The automation of routine light transmission platelet aggregation. Int J Lab Hematol: 2014; 36 4 431 438
49. Sun B., Tandon N. N., Yamamoto N., Yoshitake M., Kambayashi J. Luminometric assay of platelet activation in 96-well microplate. Biotechniques: 2001; 31 5 1174, 1176, 1178 passim
50. Moran N., Kiernan A., Dunne E., Edwards R. J., Shields D. C., Kenny D. Monitoring modulators of platelet aggregation in a microtiter plate assay. Anal Biochem: 2006; 357 1 77 84
51. Chan M. V., Armstrong P. C., Papalia F., Kirkby N. S., Warner T. D. Optical multichannel (optimul) platelet aggregometry in 96-well plates as an additional method of platelet reactivity testing. Platelets: 2011; 22 7 485 494
52. Chan M. V., Warner T. D. Standardised optical multichannel (optimul) platelet aggregometry using high-speed shaking and fixed time point readings. Platelets: 2012; 23 5 404 408
53. Lordkipanidzé M., Lowe G. C., Kirkby N. S., et al. UK Genotyping and Phenotyping of Platelets Study Group. Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assay. Blood: 2014; 123 8 e11 e22
54. Mylotte D., Kavanagh G. F., Peace A. J., et al. Platelet reactivity in type 2 diabetes mellitus: a comparative analysis with survivors of myocardial infarction and the role of glycaemic control. Platelets: 2012; 23 6 439 446
55. Cooke N. M., Egan K., McFadden S., et al. Increased platelet reactivity in patients with late-stage metastatic cancer. Cancer Med: 2013; 2 4 564 570
56. Cardinal D. C., Flower R. J. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods: 1980; 3 2 135 158
57. Solomon C., Traintinger S., Ziegler B., et al. Platelet function following trauma. A multiple electrode aggregometry study. Thromb Haemost: 2011; 106 2 322 330
58. Valarche V., Desconclois C., Boutekedjiret T., Dreyfus M., Proulle V. Multiplate whole blood impedance aggregometry: a new tool for von Willebrand disease. J Thromb Haemost: 2011; 9 8 1645 1647
59. Aradi D., Storey R. F., Komócsi A., et al. Working Group on Thrombosis of the European Society of Cardiology. Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention. Eur Heart J: 2014; 35 4 209 215
60. Würtz M., Hvas A. M., Christensen K. H., Rubak P., Kristensen S. D., Grove E. L. Rapid evaluation of platelet function using the Multiplate® Analyzer. Platelets: 2014; 25 8 628 633
61. Rubak P., Villadsen K., Hvas A. M. Reference intervals for platelet aggregation assessed by multiple electrode platelet aggregometry. Thromb Res: 2012; 130 3 420 423
62. Stissing T., Dridi N. P., Ostrowski S. R., Bochsen L., Johansson P. I. The influence of low platelet count on whole blood aggregometry assessed by Multiplate. Clin Appl Thromb Hemost: 2011; 17 6 E211 E217
63. Kong R., Trimmings A., Hutchinson N., et al. Consensus recommendations for using the Multiplate(®) for platelet function monitoring before cardiac surgery. Int J Lab Hematol: 2015; 37 2 143 147
64. Albanyan A., Al-Musa A., AlNounou R., et al. Diagnosis of Glanzmann thrombasthenia by whole blood impedance analyzer (MEA) vs. light transmission aggregometry. Int J Lab Hematol: 2015; 37 4 503 508
65. Wang J. C., Aucoin-Barry D., Manuelian D., et al. Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay-ASA. Am J Cardiol: 2003; 92 12 1492 1494
66. van Werkum J. W., Harmsze A. M., Elsenberg E. H., Bouman H. J., ten Berg J. M., Hackeng C. M. The use of the VerifyNow system to monitor antiplatelet therapy: a review of the current evidence. Platelets: 2008; 19 7 479 488
67. 12 receptor for adenosine diphosphate. Thromb Res: 2014; 133 2 254 256
68. Koessler J., Ehrenschwender M., Kobsar A., Brunner K. Evaluation of the new INNOVANCE® PFA P2Y cartridge in patients with impaired primary haemostasis. Platelets: 2012; 23 8 571 578
69. 12 receptor inhibition. Platelets: 2011; 22 1 20 27
70. Edwards A., Jakubowski J. A., Rechner A. R., Sugidachi A., Harrison P. Evaluation of the INNOVANCE PFA P2Y test cartridge: sensitivity to P2Y(12) blockade and influence of anticoagulant. Platelets: 2012; 23 2 106 115
71. Carcao M. D., Blanchette V. S., Stephens D., et al. Assessment of thrombocytopenic disorders using the Platelet Function Analyzer (PFA-100). Br J Haematol: 2002; 117 4 961 964
72. Cho Y. U., Jang S., Park C. J., Chi H. S. Variables that affect platelet function analyzer-100 (PFA-100) closure times and establishment of reference intervals in Korean adults. Ann Clin Lab Sci: 2008; 38 3 247 253
73. Jilma B. Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med: 2001; 138 3 152 163
74. Favaloro E. J. Clinical application of the PFA-100. Curr Opin Hematol: 2002; 9 5 407 415
75. Favaloro E. J. Clinical utility of the PFA-100. Semin Thromb Hemost: 2008; 34 8 709 733
76. Hayward C. P., Harrison P., Cattaneo M., Ortel T. L., Rao A. K.; Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost: 2006; 4 2 312 319
77. Chen A., Teruya J. Global hemostasis testing thromboelastography: old technology, new applications. Clin Lab Med: 2009; 29 2 391 407
78. Luddington R. J. Thromboelastography/thromboelastometry. Clin Lab Haematol: 2005; 27 2 81 90
79. Blais N., Pharand C., Lordkipanidzé M., Sia Y. K., Merhi Y., Diodati J. G. Response to aspirin in healthy individuals. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2). Thromb Haemost: 2009; 102 2 404 411
80. Scharbert G., Auer A., Kozek-Langenecker S. Evaluation of the Platelet Mapping Assay on rotational thromboelastometry ROTEM. Platelets: 2009; 20 2 125 130
81. Chitlur M., Lusher J. Standardization of thromboelastography: values and challenges. Semin Thromb Hemost: 2010; 36 7 707 711
82. Ramström S., Södergren A. L., Tynngård N., Lindahl T. L. Platelet function determined by flow cytometry: new perspectives? Semin Thromb Hemost: 2016; 42 3 268 281
83. Rubak P., Nissen P. H., Kristensen S. D., Hvas A. M. Investigation of platelet function and platelet disorders using flow cytometry. Platelets: 2016; 27 1 66 74
84. Schmitz G., Rothe G., Ruf A., et al. European Working Group on Clinical Cell Analysis: Consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemost: 1998; 79 5 885 896
85. Matzdorff A. Platelet function tests and flow cytometry to monitor antiplatelet therapy. Semin Thromb Hemost: 2005; 31 4 393 399
86. Frelinger A. L. III, Grace R. F., Gerrits A. J., et al. Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP. Blood: 2015; 126 7 873 879
87. Lee J. A., Spidlen J., Boyce K., et al. International Society for Advancement of Cytometry Data Standards Task Force. MIFlowCyt: the minimum information about a Flow Cytometry Experiment. Cytometry A: 2008; 73 10 926 930
88. Coller B. S. Historical perspective and future directions in platelet research. J Thromb Haemost: 2011; 9 01 374 395
89. Michelson A. D. Antiplatelet therapies for the treatment of cardiovascular disease. Nat Rev Drug Discov: 2010; 9 2 154 169
90. Aradi D., Kirtane A., Bonello L., et al. Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention. Eur Heart J: 2015; 36 27 1762 1771
91. de Witt S. M., Swieringa F., Cavill R., et al. Identification of platelet function defects by multi-parameter assessment of thrombus formation. Nat Commun: 2014; 5 4257